✨ Your Portfolio is fetched and updated from zerodha.
Small Chemicals

Rossari Biotech Ltd.

ROSSARI

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹3,604 Cr.
P/E
26.38

Rossari Biotech Ltd.

  • Rossari Biotech
  • SH Kelkar & Co
  • Oriental Aromatics

FAQs on Rossari Biotech Ltd. Shareprice

Rossari Biotech has given lower returns compared to its competitors.
Rossari Biotech has grown at ~-17.12% over the last 4yrs while peers have grown at a median rate of -10.38%

Rossari Biotech is not expensive.
Latest PE of Rossari Biotech is 26.38, while 3 year average PE is 45.51.
Also latest EV/EBITDA of Rossari Biotech is 14.14 while 3yr average is 24.23.

View FAQ's On Business

Growth Table

  • Rossari Biotech Ltd.
  • SH Kelkar & Co
  • Oriental Aromatics

Balance Sheet

  • Rossari Biotech Ltd.
  • SH Kelkar & Co
  • Oriental Aromatics

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Rossari Biotech Ltd.
  • SH Kelkar & Co
  • Oriental Aromatics

Cash Flow

  • Rossari Biotech Ltd.
  • SH Kelkar & Co
  • Oriental Aromatics

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Rossari Biotech Ltd.
  • SH Kelkar & Co
  • Oriental Aromatics

Quarterly Results

  • Rossari Biotech Ltd.
  • SH Kelkar & Co
  • Oriental Aromatics

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Rossari Biotech Ltd. Financials

Balance sheet of Rossari Biotech is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Rossari Biotech is increasing.
Latest net debt of Rossari Biotech is ₹272 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹74.55 Crs.

The profit is oscillating.
The profit of Rossari Biotech is ₹135 Crs for TTM, ₹136 Crs for Mar 2025 and ₹131 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Rossari Biotech latest dividend payout ratio is 2.03% and 3yr average dividend payout ratio is 2.24%

NA

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech